PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment.
Leukemia
; 31(7): 1645-1647, 2017 07.
Article
in En
| MEDLINE
| ID: mdl-28366935
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyrimidines
/
Protein-Tyrosine Kinases
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Drug Resistance, Neoplasm
/
Protein Kinase Inhibitors
/
Phospholipase C gamma
/
C2 Domains
/
Mutation
Limits:
Humans
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: